Upcoming Webinar
Start bookmarking content to consume it later
Start bookmarking content to consume it later
Start bookmarking content to consume it later
Multiple Myeloma • 18 Min Watch
Exploring Optimal Duration of Lenalidomide Maintenance after ASCT
Best evidence for Lenalidomide maintenance after ASCT came from Meta-analysis of 3 trials (McCarthy et al, JCO 207) confirmed significant OS benefit w...
0
0
Multiple-Myeloma • 22 Min Watch
Importance of identifying High Risk Patients in Multiple Myeloma
N/A
2
2
Myelodysplastic Syndromes • 00 Min Watch
Factors that influence treatment adherence and outcomes in MDS
Anticipate & manage adverse events to optimize treatment outcomes: Patients treated with hypomethylating agents are at increased risk of cytopenias & ...
0
0
Myelodysplastic Syndromes • 38 Min Watch
Duration of treatment does it improve outcomes Hypomethylating agents in MD
.
2
2
